France Cosmetovigilance Market Size, Share, and COVID-19 Impact Analysis, By Service Type (Pre-marketing, Post-marketing), By Phase Type (Pre-clinical, Phase I, Phase II, Phase III, and Phase IV), and France Cosmetovigilance Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI12528
PAGES 215
REPORT FORMAT PathSoft

France Cosmetovigilance Market Insights Forecasts to 2035 

  • The France Cosmetovigilance Market Size was estimated at USD 778.1 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 3.35% from 2025 to 2035
  • The France Cosmetovigilance Market Size is Expected to Reach USD 1118.5 Million by 2035

France Cosmetovigilance Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, the France Cosmetovigilance Market is anticipated to reach USD 1118.5 million by 2035, growing at a CAGR of 3.35% from 2025 to 2035. This is due to the growing demand for cosmetic products, the increased value placed on appearance, and individual disposable income are the main factors propelling the market expansion.

 

Market Overview 

The France cosmetovigilance market refers to the process of collecting, evaluating, and monitoring spontaneous reports of adverse effects that occur with the use of cosmetic products under normal or predictable conditions. The first study of the cosmetovigilance system itself was conducted in France as far back as 2002. The French agency responsible for safety related to health products (Afssaps) has been in charge of cosmetic product safety. There have been attempts to establish a French post-marketing surveillance system for cosmetics, and a working group has been created specifically on that issue. The statistics have three objectives: public health concerns about at-risk ingredients in cosmetic products: animal derivatives, glycol ethers, aluminium, camphor, etc; notification of adverse reactions (standardised forms for adverse reaction notifications); follow-up of quality controls in the laboratory: emergency and routine controls. The increasing emphasis on physical appearance, increasing consumption of cosmetic items, and an increase in individual disposable income are important drivers contributing to market growth. Furthermore, the surveillance of cosmetic products driven by consumers' increasing use of cosmetic products is also expected to increase demand in the future.

 

Report Coverage

This research report categorizes the market for the France cosmetovigilance market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France cosmetovigilance market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France cosmetovigilance market. 

 

France Cosmetovigilance Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 778.1 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :3.35%
2035 Value Projection:USD 1118.5 Million
Historical Data for:2020-2023
No. of Pages:215
Tables, Charts & Figures:120
Segments covered:By Service Type, By Phase Type and COVID-19 Impact Analysis
Companies covered:: PharSafer, AB Cube, OC Vigilance, Di Renzo, Proclinical, Accenture, Others.
Pitfalls & Challenges:COVID-19 Impact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The France cosmetovigilance market is driven by the cosmetic products hit the shelves, manufacturers must ensure the safety of both the products' ingredients and finished products. These must also gather evidence about any adverse reactions. Key drivers determining cosmetic penetration include increasing average daily utilization of social media, introduction of new products, and increasing demand in developing economies. 

 

Restraining Factors

The France cosmetovigilance market is restricted because the cosmetovigilance system isn't limited to the research of adverse reactions relating to cosmetic products. It'll be looking into potential public health issues relating to ingredients, and will rely on laboratory controls. 

 

Market Segmentation

The France cosmetovigilance market share is classified into service type and phase type.
 

  • The post-marketing segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France cosmetovigilance market is segmented by service type into pre-marketing and post-marketing. Among these, the post-marketing segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because there is a greater need for cosmetovigilance services to reduce the negative effects (UEs) and significant negative effects (SUEs) linked to cosmetic use.  Furthermore, the cosmetics industry is primarily responsible for the analysis and reporting of negative reactions associated with cosmetic products.

 

  • The phase IV segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France cosmetovigilance market is segmented by phase type into pre-clinical, phase I, phase II, phase III, and phase IV. Among these, the phase IV segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. For the cosmetics undergoing clinical trials, these stages provide an additional degree of security.  Clinical trials in phase IV are essential because it is enabling the detection of possible adverse drug reactions.  The data collected and assessed during this phase is therefore anticipated to be of the highest significance after the product is commercialized, due to the extensive drug testing conducted on a large patient base.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France cosmetovigilance market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

 

List of Key Companies

  • PharSafer
  • AB Cube
  • OC Vigilance
  • Di Renzo
  • Proclinical
  • Accenture
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Cosmetovigilance Market based on the below-mentioned segments:

 

France Cosmetovigilance Market, By Service Type                                                       

  • Pre-marketing
  • Post-marketing

 

France Cosmetovigilance Market, By Phase Type                                                        

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

 

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies